İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

PELİN KILIÇ

DOKTOR ÖĞRETİM ÜYESİ

ANKARA ÜNİVERSİTESİ KÖK HÜCRE ENSTİTÜSÜ KÖK HÜCRE VE YENİLEYİCİ TIP ANABİLİM DALI

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmakoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 21
  • Proje 0
  • Kitap 0
  • Bildiri 21
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 4 Q2 7 Q3 4 Q4 3
WoS (JCR) Q1 4 Q2 4 Q3 4 Q4 5
TR Index 9 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 2
Ort. yüzdelik 63.0%
Üst %1 payı 0.0%
Üst %10 payı 14.3%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 21 yayın

Scopus (SJR)
Q1 4 Q2 7 Q3 4 Q4 3
WoS (JCR)
Q1 4 Q2 4 Q3 4 Q4 5
TR Index
9 makale

Makale listesi

  1. 2025 The intersection of CAR-T immunotherapy with emerging technologies Cytokine & Growth Factor Reviews DOI 10.1016/j.cytogfr.2025.11.001 YÖKSİS SJR Q1 JCR Q1 OpenAlex 69.1%
  2. 2024 Residual protein analysis by SDS–PAGE in clinically manufactured BM‐MSC products ELECTROPHORESIS DOI 10.1002/elps.202300286 YÖKSİS SJR Q2 JCR Q3 OpenAlex 82.2%
  3. 2024 A REVIEW OF PEDIOCINS AND PEDIOCIN-LIKE BACTERIOCINS (PLBs) Latin American Applied Research - An international journal DOI 10.52292/j.laar.2024.1210 YÖKSİS SJR Q4 JCR Q4 OpenAlex 53.2%
  4. 2022 SARS-CoV-2 Mutations and their Viral Variants Elsevier BV DOI 10.1016/j.cytogfr.2021.06.001 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.8%
  5. 2021 Host variations in SARS-CoV-2 infection TURKISH JOURNAL OF BIOLOGY DOI 10.3906/biy-2104-67 YÖKSİS TR Index SJR Q2 JCR Q2 OpenAlex 51.9%
  6. 2020 stem cells and psyche:perspectives and a review of the literature journal of oncological sciences DOI 10.37047/jos.2019-71899 YÖKSİS TR Index SJR Q4 OpenAlex 41.2%
  7. 2020 Where is human-based cellular pharmaceutical R&D taking us in cartilage regeneration? 3 Biotech DOI 10.1007/s13205-020-2134-5 YÖKSİS SJR Q2 JCR Q3 OpenAlex 74.2%
  8. 2020 Utility investigation of automated techniques in hematopoietic progenitor cell count and viability assessment in the Good Manufacturing Practice (GMP) setting Experimental Biomedical Research DOI 10.30714/j-ebr.2020463606 YÖKSİS TR Index OpenAlex 46.6%
  9. 2020 Understanding factors affecting human chondrocyte culturing: an experimental study Cell and Tissue Banking DOI 10.1007/s10561-020-09847-y YÖKSİS SJR Q3 JCR Q4 OpenAlex 75.2%
  10. 2019 A CD34+ Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System Cells Tissues Organs DOI 10.1159/000501167 YÖKSİS SJR Q2 JCR Q2 OpenAlex 49.2%
  11. 2023 It isn't over ‘till it’s over: A continuing concern of the SARS-CoV-2 variants, and miRNAs targeting the S protein as a probable absolute cure Experimental Biomedical Research DOI https://experimentalbiomedicalresearch.com/ojs/index.php/ebr/article/view/338 YÖKSİS TR Index
  12. 2021 SARS-CoV-2 Mutations and their Viral Variants Cytokine and Growth Factor Reviews DOI 10.1016/j.cytogfr.2021.06.001 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.8%
  13. 2021 Host Variations in the SARS-CoV-2 Infection TURKISH JOURNAL OF BIOLOGY DOI 10.3906/biy-2104-67 YÖKSİS TR Index SJR Q2 JCR Q2 OpenAlex 51.7%
  14. 2020 Where is human-based cellular pharmaceutical RD taking us in cartilage regeneration 3Biotech YÖKSİS SJR Q2 JCR Q3
  15. 2020 Results of reference pricing and reimbursement discount rate schemes of Turkey FARMECONOMIA YÖKSİS JCR Q4
  16. 2020 Stem Cells and Psyche: Perspectives and a Review of the Literature JOS DOI 10.37047/jos.2019-71899 YÖKSİS TR Index SJR Q4 OpenAlex 41.2%
  17. 2020 Utility investigation of automated techniques in hematopoietic progenitor cell count and viability assessment in the Good Manufacturing Practice (GMP) setting Experimental Biomedical Research DOI http://llmdergi.org/upload/documents/2020-4-3-50-54%20Ekin%20Kircali.pdf YÖKSİS TR Index
  18. 2019 A CD34+ Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System Cells Tissues Organs DOI 10.1159/000501167 YÖKSİS SJR Q2 JCR Q2 OpenAlex 49.2%
  19. 2018 Cellular therapies: Day by day, all the way TRANSFUSION AND APHERESIS SCIENCE YÖKSİS SJR Q3 JCR Q4
  20. 2016 Imatinib and Norimatinib Plasma Levels Analyses of Chronic Myeloid Leukemia Patients Türkiye Klinikleri Journal of Pharmacy Sciences YÖKSİS TR Index

Akademisyenlere dön